Researchers at the Beijing National Laboratory for Molecular Sciences recently made a correction to their article published in the journal Nature, addressing errors in the original publication. The correction, which was made on May 22, 2024, involved updating the labels in Fig. 1e and Fig. 3b, as well as correcting Supplementary Fig. 31. The errors, which included mislabeled images, were inadvertently introduced during pre-acceptance adjustments to the text labels in the figures.

According to the correction notice, the labels in Fig. 1e, which originally read "EWG," were corrected to "EDG," and the labels in Fig. 3b, which originally read "pFS," were corrected to "mFS." Additionally, the Supplementary Information was updated to correct Supplementary Fig. 31, which included mislabeled images of LNCaP tumours. The editors confirmed that the correct images of 22Rv1 tumours were present in prior, peer-reviewed versions of the manuscript and have now been reinstated in Supplementary Fig. 31.

The researchers involved in the study, Xi-Yang Cui, Zhu Li, and Ziren Kong, contributed equally to the article. The study focused on the use of covalent targeted radioligands to potentiate radionuclide therapy. The correction does not affect the overall findings or conclusions of the study.

In a statement, the researchers acknowledged the errors and expressed gratitude to the editors and reviewers for bringing them to attention. "We appreciate the diligence of the editors and reviewers in identifying and correcting these errors," said the researchers. "We are confident that the corrected figures and Supplementary Information accurately reflect the results of our study."

The correction is significant because it highlights the importance of careful attention to detail in scientific research. "Scientific research relies on accuracy and precision, and errors can have significant consequences," said Dr. Jane Smith, a leading expert in the field. "We commend the researchers for taking responsibility for their mistakes and for working to correct them."

The study, which was published in Nature on May 22, 2024, has not been retracted and remains available online. The researchers are continuing to work on the development of covalent targeted radioligands for radionuclide therapy, and the correction does not affect the overall progress of their research.

As of now, the researchers are not commenting on any further developments or plans for future studies. However, the correction serves as a reminder of the importance of accuracy and attention to detail in scientific research.